Genpact Limited (G) Upgraded to Buy at Zacks Investment Research

Genpact Limited (NYSE:G) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Friday, April 14th. The firm currently has a $27.00 price target on the business services provider’s stock. Zacks Investment Research‘s target price would indicate a potential upside of 2.35% from the company’s previous close.

According to Zacks, “Genpact manages business processes for companies around the world. The company combines process expertise, information technology and analytical capabilities with operational insight and experience in diverse industries to provide a wide range of services using its global delivery platform. Genpact helps companies improve the ways in which they do business by applying Six Sigma and Lean principles plus technology to continuously improve their business processes. Genpact operates service delivery centers in India, China, Hungary, Mexico, the Philippines, the Netherlands, Romania, Spain and the United States. “

Several other brokerages also recently commented on G. Cantor Fitzgerald reissued an “overweight” rating and issued a $27.00 price objective on shares of Genpact Limited in a research note on Friday, February 10th. Jefferies Group LLC reaffirmed a “buy” rating on shares of Genpact Limited in a research report on Friday, March 17th. Finally, BMO Capital Markets reaffirmed a “hold” rating and set a $25.00 price target on shares of Genpact Limited in a research report on Thursday, March 23rd. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and six have issued a buy rating to the company’s stock. Genpact Limited presently has a consensus rating of “Buy” and a consensus target price of $28.38.

Analyst Recommendations for Genpact Limited (NYSE:G)

Shares of Genpact Limited (NYSE:G) traded up 0.701% on Friday, hitting $26.565. The company had a trading volume of 922,949 shares. The company has a market capitalization of $5.12 billion, a P/E ratio of 20.868 and a beta of 0.63. The firm has a 50-day moving average price of $24.65 and a 200 day moving average price of $24.29. Genpact Limited has a 12-month low of $22.58 and a 12-month high of $28.47.

Genpact Limited (NYSE:G) last issued its quarterly earnings data on Thursday, May 4th. The business services provider reported $0.29 EPS for the quarter, hitting the consensus estimate of $0.29. The firm had revenue of $623 million during the quarter, compared to the consensus estimate of $614.84 million. Genpact Limited had a return on equity of 21.52% and a net margin of 10.49%. The company’s quarterly revenue was up 2.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.31 earnings per share. Equities analysts expect that Genpact Limited will post $1.55 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Genpact Limited (G) Upgraded to Buy at Zacks Investment Research” was first reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright legislation. The legal version of this piece can be accessed at https://www.com-unik.info/2017/05/19/zacks-investment-research-upgrades-genpact-limited-g-to-buy-updated-updated-updated.html.

In other news, insider N. V. Tyagarajan sold 198,642 shares of the firm’s stock in a transaction on Thursday, March 9th. The stock was sold at an average price of $24.09, for a total value of $4,785,285.78. Following the completion of the transaction, the insider now directly owns 477,787 shares of the company’s stock, valued at $11,509,888.83. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director James C. Madden sold 5,224 shares of the firm’s stock in a transaction on Friday, May 12th. The stock was sold at an average price of $25.51, for a total value of $133,264.24. Following the completion of the transaction, the director now directly owns 8,970 shares of the company’s stock, valued at $228,824.70. The disclosure for this sale can be found here. Over the last three months, insiders have sold 213,866 shares of company stock valued at $5,163,550. 1.55% of the stock is owned by corporate insiders.

Institutional investors have recently bought and sold shares of the company. SG Americas Securities LLC bought a new position in Genpact Limited during the first quarter worth approximately $110,000. Public Employees Retirement Association of Colorado increased its stake in shares of Genpact Limited by 0.4% in the third quarter. Public Employees Retirement Association of Colorado now owns 4,848 shares of the business services provider’s stock worth $116,000 after buying an additional 21 shares during the period. Bronfman E.L. Rothschild L.P. increased its stake in shares of Genpact Limited by 42.5% in the first quarter. Bronfman E.L. Rothschild L.P. now owns 4,959 shares of the business services provider’s stock worth $123,000 after buying an additional 1,480 shares during the period. BNP Paribas Arbitrage SA increased its stake in shares of Genpact Limited by 85.3% in the first quarter. BNP Paribas Arbitrage SA now owns 5,220 shares of the business services provider’s stock worth $129,000 after buying an additional 2,403 shares during the period. Finally, OLD Mutual Customised Solutions Proprietary Ltd. acquired a new stake in shares of Genpact Limited during the first quarter worth about $168,000. 90.37% of the stock is owned by hedge funds and other institutional investors.

About Genpact Limited

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

5 Day Chart for NYSE:G

Get a free copy of the Zacks research report on Genpact Limited (G)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

What are top analysts saying about Genpact Limited? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Genpact Limited and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit